Pharma company Novartis India today said its net profit rose by 22.30% to Rs 34 crore for the fourth quarter ended March 31, 2011, over the same period previous fiscal.
The company had a net profit of Rs 27.8 crore in the same period last fiscal, Novartis India said in a filing to the Bombay Stock Exchange (BSE).
Its net sales rose to Rs 171.4 crore for the quarter ended March 31, 2011, compared to Rs 148.9 crore in the same period previous fiscal.
For the year ended March 31, 2011, the company posted a net profit of Rs 146.6 crore, as against Rs 115.9 crore in the last fiscal.
The company's net sales on annual basis rose to Rs 708.6 crore from Rs 624.1 crore in the previous fiscal.
The company's board also recommended a dividend of Rs 10 a equity share of Rs 5 each for the year ended March 31, 2011.
Shares of Novartis India today closed at Rs 700.70 on the BSE, down 1.53% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app